第 1 到 58 筆結果,共 58 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Lung adenocarcinoma with neuroendocrine differentiation: Molecular markers testing and treatment outcomes | HAO-CHUN CHANG ; KUAN-YU CHEN ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
2 | 2021 | Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer | Lin, Chia-Yi; Huang, Kuo-Yen; Lin, Yi-Chun; Yang, Shuenn-Chen; Chung, Wei-Chia; YIH-LEONG CHANG ; JIN-YUAN SHIH ; CHAO-CHI HO ; Lin, Chih-An; Shih, Chih-Chun; Chang, Ya-Hsuan; Kao, Shih-Han; PAN-CHYR YANG | Cancer letters | 19 | 13 | |
3 | 2021 | Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1 | KUEI-PIN CHUNG ; YEN-LIN HUANG ; Chen, Yi-Jung; Juan, Yi-Hsiu; Hsu, Chia-Lang ; Nakahira, Kiichi; Huang, Yen-Tsung; MONG-WEI LIN ; SHANG-GIN WU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; CHONG-JEN YU | Molecular Oncology | 10 | 8 | |
4 | 2020 | Successful management of a ROS1-rearranged pulmonary pleomorphic carcinoma using serial tyrosine kinase inhibitors | Wu C.-W.; CHING-YAO YANG ; YIH-LEONG CHANG ; JIN-YUAN SHIH | OncoTargets and Therapy | 1 | 1 | |
5 | 2020 | Primary resistance to osimertinib despite acquired T790M | Chang L.-K.; YIH-LEONG CHANG ; JIN-YUAN SHIH | Respirology Case Reports | 3 | 2 | |
6 | 2020 | Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors | CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; Chia-Chi Hsu; BIN-CHI LIAO ; Wei-Hsun Hsu; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | European Journal of Cancer | 55 | 49 | |
7 | 2020 | Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib | CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Liu, Yi-Nan; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; BIN-CHI LIAO ; Hsu, Chia-Chi; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | Oncologist | 15 | 15 | |
8 | 2019 | Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer | Liu Y.-N.; Tsai M.-F.; SHANG-GIN WU ; Chang T.-H.; TZU-HSIU TSAI ; Gow C.-H.; YIH-LEONG CHANG ; JIN-YUAN SHIH | International Journal of Cancer | 34 | 34 | |
9 | 2019 | IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer | SHANG-GIN WU ; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; CHIA-LANG HSU ; YIH-LEONG CHANG ; CHONG-JEN YU ; JIN-YUAN SHIH | Cancers | 15 | 12 | |
10 | 2018 | Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan | SHU-YUNG LIN ; Yang C.-Y.; BIN-CHI LIAO ; CHAO-CHI HO ; WEI-YU LIAO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Hsu W.-H.; KANG-YI SU ; YIH-LEONG CHANG ; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | Journal of Cancer | 40 | 41 | |
11 | 2018 | Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study | CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHAO-CHI HO ; WEI-YU LIAO ; JIH-HSIANG LEE ; TZU-HSIU TSAI ; KANG-YI SU ; MIN-SHU HSIEH ; YIH-LEONG CHANG ; Bai Y.-Y.; DE-RUI HUANG ; Thress K.S.; CHIH-HSIN YANG | The Lancet Respiratory Medicine | 120 | 109 | |
12 | 2017 | Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors | SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | ERJ open research | 34 | 0 | |
13 | 2017 | Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C | Chang, Tzu-Hua; Tsai M.-F.; Gow, Chien-Hung; SHANG-GIN WU ; Liu, Yi-Nan; YIH-LEONG CHANG ; SUNG-LIANG YU ; HSING-CHEN TSAI ; Lin, Shih-Wen; Chen, Yen-Wei; Kuo, Po-Yen; PAN-CHYR YANG ; JIN-YUAN SHIH | Cancer letters | 48 | 47 | |
14 | 2017 | Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression | CHUNG-YU CHEN ; Chen Y.-Y.; Chen J.J.W.; KUAN-YU CHEN ; CHAO-CHI HO ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG | Oncotarget | 9 | 9 | |
15 | 2016 | Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations | YEN-FU CHEN ; MIN-SHU HSIEH ; SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 63 | 51 | |
16 | 2016 | The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition | SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | Scientific Reports | 32 | 28 | |
17 | 2016 | The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients | SHANG-GIN WU ; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; CHIH-HSIN YANG ; Wen Y.-F.; JIN-YUAN SHIH | Oncotarget | 207 | 191 | |
18 | 2015 | DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers | Lin Y.-C.; Lin Y.-C.; JIN-YUAN SHIH ; Huang W.-J.; Chao S.-W.; YIH-LEONG CHANG ; CHING-CHOW CHEN | Clinical Cancer Research | 36 | 34 | |
19 | 2014 | Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case | Gow C.-H.; SHANG-GIN WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH | Medical Oncology | 24 | 21 | |
20 | 2014 | Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension | MONG-WEI LIN ; CHEN-TU WU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; PAN-CHYR YANG | Journal of Surgical Oncology | 32 | 29 | |
21 | 2014 | Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations | YEN-FU CHEN ; MIN-SHU HSIEH ; SHANG-GIN WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; Liu Y.-N.; Tsai M.-F.; TZU-HSIU TSAI ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Journal of Thoracic Oncology | 68 | 64 | |
22 | 2013 | Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis | SHANG-GIN WU ; Hu F.-C.; YIH-LEONG CHANG ; Lee Y.-C.; CHONG-JEN YU ; YEUN-CHUNG CHANG ; Wu J.-Y.; JIN-YUAN SHIH ; PAN-CHYR YANG | European Respiratory Journal | 35 | 36 | |
23 | 2012 | The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction | YIH-LEONG CHANG ; MONG-WEI LIN ; JIN-YUAN SHIH ; CHEN-TU WU ; Lee Y.-C. | Annals of Surgical Oncology | 26 | 20 | |
24 | 2012 | Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment | KUEI-PIN CHUNG ; Huang Y.-T.; YIH-LEONG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; YEUN-CHUNG CHANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Chest | 44 | 42 | |
25 | 2012 | EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR | SHANG-GIN WU ; YAO-WEN KUO ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; Chen Y.-H.; Tsai M.-F.; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Journal of Thoracic Oncology | 90 | 72 | |
26 | 2012 | Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma | TZU-HSIU TSAI ; SHANG-GIN WU ; YIH-LEONG CHANG ; CHEN-TU WU ; Tsai M.-F.; Wei P.-F.; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 22 | 26 | |
27 | 2012 | RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer | TZU-HSIU TSAI ; KANG-YI SU ; SHANG-GIN WU ; YIH-LEONG CHANG ; Luo S.-C.; Jane I.-S.; CHONG-JEN YU ; Yue S.-L.; JIN-YUAN SHIH ; PAN-CHYR YANG | European Respiratory Journal | 42 | 37 | |
28 | 2011 | Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers | YIH-LEONG CHANG ; CHEN-TU WU ; JIN-YUAN SHIH ; Lee Y.-C. | Annals of Surgical Oncology | 44 | 38 | |
29 | 2011 | Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction | SHANG-GIN WU ; YIH-LEONG CHANG ; JOU-WEI LIN ; CHEN-TU WU ; Chen, Hsuan-Yu; Tsai, Meng-Feng; Lee, Yung-Chie; CHONG-JEN YU ; JIN-YUAN SHIH | PloS one | 49 | 43 | |
30 | 2011 | Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed | CHUNG-YU CHEN ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; JOU-WEI LIN ; KUAN-YU CHEN ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | Lung Cancer | 108 | 102 | |
31 | 2011 | Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations | SHANG-GIN WU ; CHIH-HSIN YANG ; CHONG-JEN YU ; JIH-HSIANG LEE ; Hsu Y.-C.; YIH-LEONG CHANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung Cancer | 41 | 35 | |
32 | 2011 | Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas | YIH-LEONG CHANG ; CHEN-TU WU ; JIN-YUAN SHIH ; Lee Y.-C. | Cancer Science | 63 | 58 | |
33 | 2011 | Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations | Yuan S.; SUNG-LIANG YU ; Chen H.-Y.; Hsu Y.-C.; KANG-YI SU ; HUEI-WEN CHEN ; Chen C.-Y.; CHONG-JEN YU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; PAN-CHYR YANG | Journal of Clinical Oncology | 28 | 26 | |
34 | 2011 | EGFR and p53 status of pulmonary pleomorphic carcinoma: Implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy | YIH-LEONG CHANG ; CHEN-TU WU ; JIN-YUAN SHIH ; Lee Y.-C. | Annals of Surgical Oncology | 48 | 43 | |
35 | 2011 | Epidermal growth factor receptor mutations in small cell lung cancer: A brief report | Shiao T.-H.; YIH-LEONG CHANG ; CHONG-JEN YU ; YEUN-CHUNG CHANG ; Hsu Y.-C.; Chang S.-H.; JIN-YUAN SHIH ; PAN-CHYR YANG | Journal of Thoracic Oncology | 81 | 72 | |
36 | 2011 | Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations | Wu J.-Y.; SHANG-GIN WU ; CHIH-HSIN YANG ; YIH-LEONG CHANG ; YEUN-CHUNG CHANG ; Hsu Y.-C.; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung Cancer | 69 | 61 | |
37 | 2010 | Potential roles of fibroblast growth factor-9 in the benzo(a)pyrene-induced invasion in vitro and the metastasis of human lung adenocarcinoma | YIH-LEONG CHANG ; Tsai Y.-Y.; Su J.-L.; Chan P.-K.; JIN-YUAN SHIH ; Lee Y.-C.; Ma Y.-C.; Kuo M.-L. | Archives of Toxicology | 29 | 27 | |
38 | 2009 | Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer | Gow C.-H.; YIH-LEONG CHANG ; Hsu Y.-C.; Tsai M.-F.; CHEN-TU WU ; CHONG-JEN YU ; CHIH-HSIN YANG ; Lee Y.-C.; PAN-CHYR YANG ; JIN-YUAN SHIH | Annals of Oncology | 195 | 172 | |
39 | 2008 | Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response | Gow C.-H.; Chien C.-R.; YIH-LEONG CHANG ; Chiu Y.-H.; SUNG-HSIN KUO ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Clinical Cancer Research | 132 | 125 | |
40 | 2008 | Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern | SHANG-GIN WU ; YIH-LEONG CHANG ; Hsu Y.-C.; Wu J.-Y.; CHIH-HSIN YANG ; CHONG-JEN YU ; Tsai M.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | Oncologist | 72 | 67 | |
41 | 2008 | Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma | SHANG-GIN WU ; Gow C.-H.; CHONG-JEN YU ; YIH-LEONG CHANG ; CHIH-HSIN YANG ; Hsu Y.-C.; JIN-YUAN SHIH ; Lee Y.-C.; PAN-CHYR YANG | European Respiratory Journal | 109 | 95 | |
42 | 2006 | Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer | JIN-YUAN SHIH ; Gow C.-H.; CHONG-JEN YU ; CHIH-HSIN YANG ; YIH-LEONG CHANG ; Tsai M.-F.; Hsu Y.-C.; KUAN-YU CHEN ; Su W.-P.; PAN-CHYR YANG | International Journal of Cancer | 154 | 142 | |
43 | 2006 | Estrogen receptor β - Which one and where should we draw the line - Reply [2] | CHEN-TU WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; Lee Y.-C. | Human Pathology | 0 | 0 | |
44 | 2005 | The significance of estrogen receptor β in 301 surgically treated non-small cell lung cancers | CHEN-TU WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; Lee Y.-C. | Journal of Thoracic and Cardiovascular Surgery | 162 | 143 | |
45 | 2005 | Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R | Gow C.-H.; JIN-YUAN SHIH ; YIH-LEONG CHANG ; CHONG-JEN YU | PLoS Medicine | 25 | 0 | |
46 | 2005 | Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma | JIN-YUAN SHIH ; Tsai M.-F.; Chang T.-H.; YIH-LEONG CHANG ; ANG YUAN ; CHONG-JEN YU ; Lin S.-B.; Liou G.-Y.; Lee M.-L.; Chen J.J.W.; Hong T.-M.; Yang S.-C.; Su J.-L.; Lee Y.-C.; PAN-CHYR YANG | Clinical Cancer Research | 194 | 184 | |
47 | 2004 | Cardiac involvement in malignancies: Case 1. Favorable outcome of a patient with cardiac invasion from non-small-cell lung carcinoma | MIN-SHAN TSAI ; PATRICK CHOW-IN KO ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; SHYR-CHYR CHEN ; WEN-CHU CHIANG ; WEN-JONE CHEN | Journal of Clinical Oncology | 4 | 4 | |
48 | 2004 | Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers | Lee Y.-C.; CHEN-TU WU ; JIN-YUAN SHIH ; Jou Y.-S.; YIH-LEONG CHANG | British Journal of Cancer | 14 | 14 | |
49 | 2003 | Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers | YIH-LEONG CHANG ; CHEN-TU WU ; JIN-YUAN SHIH ; Lee Y.-C. | British Journal of Cancer | 11 | 10 | |
50 | 2003 | Tuberculous myositis: A rare but existing clinical entity | JANN-YUAN WANG ; LI-NA LEE ; PO-REN HSUEH ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; PAN-CHYR YANG ; KWEN-TAY LUH | Rheumatology | 68 | 57 | |
51 | 2002 | New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas | YIH-LEONG CHANG ; CHEN-TU WU ; JIN-YUAN SHIH ; Lee Y.-C. | American Journal of Surgical Pathology | 104 | 84 | |
52 | 2001 | Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells | JIN-YUAN SHIH ; PAN-CHYR YANG ; Hong T.-M.; ANG YUAN ; Chen J.J.W.; CHONG-JEN YU ; YIH-LEONG CHANG ; Lee Y.-C.; Peck K.; Wu C.-W.; Yang P.-C. | Journal of the National Cancer Institute | 135 | 126 | |
53 | 2001 | Pulmonary pleomorphic (spindle) cell carcinoma: Peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma | YIH-LEONG CHANG ; Lee Y.-C.; JIN-YUAN SHIH ; CHEN-TU WU | Lung Cancer | 174 | 135 | |
54 | 1998 | Primary pulmonary plasmacytoma with lobar consolidation: An unusual presentation | KUAN-YU CHEN ; Wu H.-D.; YIH-LEONG CHANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 12 | 8 | |
55 | 1998 | Tracheal botryomycosis in a patient with tracheopathia osteochondroplastica | JIN-YUAN SHIH ; PO-REN HSUEH ; YIH-LEONG CHANG ; LI-NA LEE ; YEE-CHUN CHEN ; MING-FONG CHEN ; KWEN-TAY LUH | Thorax | 21 | 16 | |
56 | 1997 | Osteomyelitis and tenosynovitis due to Mycobacterium marinum in a fish dealer | JIN-YUAN SHIH ; PO-REN HSUEH ; YIH-LEONG CHANG ; Chen M.-T.; PAN-CHYR YANG ; KWEN-TAY LUH | Journal of the Formosan Medical Association | 25 | 19 | |
57 | 1997 | Sonographic imaging of the trachea | JIN-YUAN SHIH ; LI-NA LEE ; Wu H.-D.; CHONG-JEN YU ; HAO-CHIEN WANG ; YIH-LEONG CHANG ; PAN-CHYR YANG | Journal of Ultrasound in Medicine | 22 | 19 | |
58 | 1996 | Echogenic floating spherules as a sonographic sign of cystic teratoma of mediastinum: Correlation with CT and pathologic findings | JIN-YUAN SHIH ; HAO-CHIEN WANG ; YIH-LEONG CHANG ; YEUN-CHUNG CHANG ; Lee Y.-C.; PAN-CHYR YANG | Journal of Ultrasound in Medicine | 2 | 2 |